Recombinant Human PHYH Protein ，GST

The study of PHYH recombinant protein is rooted in the increasing recognition of the vital role that phytanoyl-CoA hydroxylase (PHYH) plays in human health and metabolism. PHYH is an enzyme primarily involved in the catabolism of phytanic acid, a dietary branched-chain fatty acid. Deficiencies in PHYH have been linked to Refsum disease, a rare genetic disorder characterized by the accumulation of phytanic acid in the body, leading to severe neurological and visual impairments. Research has focused on understanding PHYH's structure, function, and enzymatic mechanisms to develop potential therapeutic approaches for related disorders. The production of recombinant PHYH protein allows for detailed biochemical studies, including enzyme kinetics and structural biology, which are essential for elucidating the pathway of phytanic acid metabolism. Additionally, recombinant PHYH can serve as a powerful tool for screening small molecule inhibitors or enhancers, which could lead to novel treatments for metabolic disorders associated with its dysfunction. The integration of advanced techniques, such as CRISPR gene editing and high-throughput screening, in the study of PHYH is expected to yield critical insights into its biological significance and pave the way for innovative therapeutic strategies. Overall, the research on PHYH recombinant protein not only contributes to our understanding of metabolic processes but also highlights the importance of addressing genetic lipid metabolism diseases in clinical settings.